Latest News

Acquisition of Quantum Pharma Plc by the Clinigen Group plc

Acquisition of Quantum Pharma Plc by the Clinigen Group plc

The acquisition of our parent company, Quantum Pharma Plc, by the Clinigen Group plc was completed on 1 November 2017.      

Posted by: Quantum Webmaster on 2nd November 2017

Unaudited results for the half year ended 31 July 2017 ('the period' or 'H1 2018')

Unaudited results for the half year ended 31 July 2017 ('the period' or 'H1 2018')

Financial Highlights Revenue increased 13% to £36.2m (H1 2017: £32.1m) reflecting strong growth from the Niche Pharmaceuticals division ('Niche') Adjusted EBITDA increased 23% to £5.7m (H1 2017: £…

Posted by: Quantum Webmaster on 22nd August 2017

Half Year Trading Update & Notice of Interim Results

Half Year Trading Update & Notice of Interim Results

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces the following trading update for the half year ended 31 July 2017 (the 'period').

Posted by: Quantum Webmaster on 9th August 2017

Disposal of Biodose Services and Trading Update

Disposal of Biodose Services and Trading Update

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces the disposal of Total Medication Management Services Limited, the Group's homecare dispensary and delivery business…

Posted by: Quantum Webmaster on 26th June 2017

Final audited results for the year ended 31 January 2017

Final audited results for the year ended 31 January 2017

Financial highlights Revenue increased by 28% to £88.8m (2016: £69.2m). Gross profit remained flat at £25.9m (2016: £25.9m). Adjusted EBITDA of £10.1m (2016: £12.5m) with…

Posted by: Quantum Webmaster on 3rd May 2017

Full Year Trading Update & Notice of Final Results

Full Year Trading Update & Notice of Final Results

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces the following trading update for the year ended 31 January 2017.

Posted by: Quantum Webmaster on 1st February 2017

Appointment of Chief Financial Officer

Appointment of Chief Financial Officer

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, is pleased to announce the appointment of Gerard (Ged) Murray to the Board as Chief Financial…

Posted by: Quantum Webmaster on 8th December 2016

Appointment of Nominated Adviser

Appointment of Nominated Adviser

Quantum Pharma plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, announces the appointment of N+1 Singer as the Company's nominated adviser and sole broker with…

Posted by: Quantum Webmaster on 1st December 2016

Result of General Meeting and £15m fundraise

Result of General Meeting and £15m fundraise

Quantum Pharma Plc (AIM: QP.) the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, announced on 20 October 2016 that the Company had raised a total of £15 million (before expenses)…

Posted by: Quantum Webmaster on 10th November 2016

Confirmation of successful £15 million fundraise subject to shareholder approval

Confirmation of successful £15 million fundraise subject to shareholder approval

Quantum Pharma Plc (AIM: QP.) is pleased to announce that, following the announcement made earlier today entitled “Proposed Accelerated Bookbuild to raise up to £15 million”, the Company has raised a total of £15…

Posted by: Quantum Webmaster on 20th October 2016